DESTINA Genomics and Mecwins join forces to develop more reliable diagnostic tests
DESTINA Genomics and Mecwins join forces to develop more reliable diagnostic tests Both biotechnology firms have signed a cross-licensing…
Read more
DESTINA featuring at Virtual Symposium On Ultrasensitive Immunoassays: The Power of Single Molecule Counting (SMC™) Technology organised by MilliporeSigma
On Wednesday 31 March 2021, DESTINA’s Juan Jose Diaz-Mochon will present the First Single Molecule Counting (SMC™) Application with miRNAs by a…
Amplification-free profiling of microRNA-122 biomarker in DILI patient serums, using the Luminex MAGPIX system
Citation: Talanta, 2020, doi: 10.1016/j.talanta.2020.121265 Abstract Dynamic chemical labelling is a single-base specific method to enable detection and quantification of micro-Ribonucleic…
Juanjo’s Eulogy for Hugh – My mentor, friend and companion
Granada 12th October 2020 I was a Spanish academic researcher living in the UK who always wanted to commercialise some…
Announcement on the Death of our CEO Hugh Ilyine
Edinburgh 23rd September 2020 It is with great sadness that DESTINA Genomics and DESTINA Genomica announce the death of our…
DESTINA Genomica S.L. joins Science Exchange
DESTINA Genomica SL has joined @Science Exchange, the global platform for outsourced R&D reagents and services. For quotations on the…